| ¿µ¹® | antisocial personality disorder | ÇÑ±Û | ¹Ý»çȸÀûÀΰÝÀå¾Ö |
|---|---|---|---|
| ¼³¸í | Áö¼ÓÀûÀ¸·Î ±×¸®°í ¸¸¼ºÀûÀ¸·Î ¹Ý»çȸÀûÀÎ ÇൿÀ» ÇÏ´Â Á¤½Å°úÀû º´. ´Ù¸¥ »ç¶÷¿¡°Ô Áø½Ç¼ºÀÌ ¾ø°í ´Ù¸¥ »ç¶÷ÀÇ ±Ç¸®³ª ÇÇÇØ¿¡´Â ÀüÇô ¹«°¨°¢ÇÏ°í ´ÜÁö ÀÚ½ÅÀÇ Ãæµ¿°ú ¿å±¸¿¡ ÀÇÇØ¼ ÇൿÀ» ÇÑ´Ù. ÀÚ½ÅÀÇ ½Ç¼ö¿¡ ´ëÇØ¼ ´Ù¸¥ »ç¶÷ÀÌ Ãæ°íÇÏ´Â °ÍÀ» ÂüÁö¸øÇϰí Ç×»ó ÀÚ½ÅÀÇ ¸¶À½´ë·Î¸¸ ÇÑ´Ù. |
||
| ¿µ¹® | anxiety disorder | ÇÑ±Û | ºÒ¾ÈÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ½É¸®Àû ºÒ¾ÈÁ¤À̳ª ºÒ¾È µîÀ» ÁÖ Æ¯Â¡À¸·Î ÇÏ´Â Á¤½Å°úÀû º´ÅÂ. ´ëÇ¥ÀûÀÎ ¿¹·Î´Â °øÆ÷Áõ(phobia)¿Í °øÈ²Àå¾Ö(panic disorder), Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder) µîÀÌ ÀÖ´Ù. °øÆ÷ÁõÀ̶õ ƯÁ¤ÇÑ Àå¼Ò³ª »óȲ¿¡ ´ëÇØ¼ º´ÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ¸·Î ±¤Àå°øÆ÷Áõ(agoraphobia): Ź Æ®ÀÎ °ø°£À» ¹«¼¿öÇÔ. »çȸ°øÆ÷Ãþ(social phobia): ´Ù¸¥ »ç¶÷¾Õ¿¡ ¼´Â °ÍÀ» ¹«¼¿ö ÇÔ. °í¼Ò°øÆ÷Ãþ(acrophobia): ³ôÀº °÷¿¡ °¡´Â °ÍÀ» ¹«¼¿öÇÔ. ÁøÆó°øÆ÷Áõ(claustrophobia): ¹ÐÆóµÈ °ø°£À» ¹«¼¿öÇÔ. µ¿¹°°øÆ÷Áõ(zoophobia): µ¿¹°À» º´ÀûÀ¸·Î ¹«¼¿öÇÔ µîÀ» Æ÷ÇÔÇÑ´Ù. °øÈ²Àå¾Ö(panic disorde)¶õ ¿ÜºÎÀÇ À§ÇèÇÑ ÀÚ±ØÀÌ ¾ø´Âµ¥µµ ºÒ±¸ÇÏ°í °©Àڱ⠱ؽÉÇÑ °øÆ÷¸¦ ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ ½ÉÀåÀÌ ½ÉÇÏ°Ô ¶Ù°Å³ª ½ÄÀº ¶¡À» È긮°í, ½Ç½Å, È£Èí°ï¶õ µîÀÇ Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder)¶õ 1°³¿ùÀÌ»ó Áö¼ÓÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ »ç¼ÒÇÑ ÀÏ»óÀÇ ÀÏ¿¡ ´ëÇÑ ºÒ¾ÈÀ» ´À³¢¸ç, ºÒ¾ÈÀÇ ´ë»óÀÌ ¾ø´Â °æ¿ì¿¡´Â ¾ðÁ¦ ºÒ¾ÈÀ» ´À³¥Áö ¸ð¸¥´Ù´Â ºÒ¾È°¨(¿¹±âºÒ¾È)À» È£¼ÒÇÑ´Ù. ´ë°³ ¼è¾à, ¾îÁö·¯¿ò, ¼Õ¶³¸², ¶¡À» È긮´Â µîÀÇ ½ÅüÀû Áõ»óÀ» µ¿¹ÝÇÑ´Ù. |
||
| ¿µ¹® | cyclothymic disorder | ÇÑ±Û | ¼øÈ¯¼ºÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼ º¯ÈÇÏÁö ¾Ê´Â Áö¼ÓÀûÀÎ ¸¶À½ÀÇ »óÅÂÀÎ ±âºÐ(mood)ÀÇ ÀÌ»óÀÌ ÀÖ´Â Á¤µ¿Àå¾Ö(affective disorder, mood disorder)ÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀÎ º´À¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïº´(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ µé¶ß´Â Á¶º´(mania)ÀÌ ÀÖ´Ù. À̱ؼº Àå¾Ö¶õ ¿ì¿ïº´°ú Á¶º´ÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ´Â Á¤½Åº´°ú Á¶º´¸¸ ÀÖ°í ¿ì¿ïº´Àº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇÏ´Â °³³äÀÌ´Ù. Áï ¿ì¿ïº´ÀÇ À¯¹«¿¡ °ü°è¾øÀÌ Á¶º´ÀÌ ÇѹøÀÌ¶óµµ ÀÖ´Â °æ¿ì À̰ÍÀ» À̱ؼº Àå¾Ö¶ó°í ÇÑ´Ù. ¼øÈ¯¼ºÀå¾Ö¶õ À̱ؼº Àå¾Ö¿Í °°ÀÌ ÈïºÐ°ú ¿ì¿ïÀÇ »óŰ¡ ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÇÏ´Â °ÍÀº ¸¶Âù°¡ÁöÀÌÁö¸¸ ÈïºÐÀ̳ª ¿ì¿ïÀÇ »óŰ¡ ÈξÀ °æÇÑ °æ¿ì¿¡ »ç¿ëµÇ´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | bipolar disorder | ÇÑ±Û | ¾ç±Ø¼º Àå¾Ö |
|---|---|---|---|
| ¼³¸í | ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼ º¯ÈÇÏÁö ¾Ê´Â Áö¼ÓÀûÀÎ ¸¶À½ÀÇ »óÅÂÀÎ ±âºÐ(mood)¿¡ ÀÌ»óÀÌ ÀÖ´Â Á¤µ¿Àå¾ÖÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀÎ ÁúȯÀ¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïÁõ(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ µé¶ß´Â Á¶Áõ(mania)ÀÌ ÀÖ´Ù. ¿ì¿ïÁõ°ú Á¶ÁõÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÀÌ µÇ´Â Á¤½ÅÁúȯ°ú Á¶Áõ¸¸ ÀÖ°í ¿ì¿ïÁõÀº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇÏ´Â °³³äÀÌ´Ù. |
||
| ¿µ¹® | language disorder | ÇÑ±Û | ¾ð¾îÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â º´Áõ. ±³Åë¼ö´ÜÀ¸·Î¼ÀÇ ¾ð¾î·Î Á¤º¸¸¦ Àü´ÞÇϴµ¥ ÀÖ¾î¼ÀÇ Àå¾ÖÀÌ´Ù. ¾ð¾î¸¦ ÀÌÇØ, Ç¥ÃâÇÏ´Â »ý¸®ÇÐÀû, ½É¸®ÇÐÀû, ¾ð¾îÇÐÀû, ¹°¸®ÇÐÀû, »çȸÇÐÀûÀÎ °¢ °úÁ¤¿¡¼ÀÇ Áúº´À̳ª Àå¾Ö·Î ÀÎÇØ ÀϾ¸ç ±× ¿øÀÎÀ̳ª º´Å¿¡ µû¶ó ±¸À½Àå¾Ö, ¸»´õµë, À½¼ºÀå¾Ö, ¾ð¾î¹ß´ÞÁöü, û·ÂÀå¾Ö, ¼±Ãµ±âÇü µî ¸¹Àº Áúº´, Àå¾Ö·Î ¼¼ºÐµÈ´Ù. ¿øÀÎ ¹× º´ÅÂÀÇ °Ë»ç, Áø´Ü¿¡´Â ³»°ú, À̺ñÀÎÈİú, Á¤½Å°ú, Ä¡°ú µî ¿©·¯ °ú¸ñ¿¡ °ÉÃÄ Á¤¹ÐÁ¶»ç¸¦ ÇÔ°ú µ¿½Ã¿¡ ¾ð¾î±â´É°Ë»ç¸¦ ÇØ¾ß ÇÑ´Ù. |
||
| PAD | pain and distress; patient surface axis depth; percutaneous abscess drainage; percutaneous automated... |
|---|---|
| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
| DD | dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional... |
| SPD | schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s... |
| MEDAC | multiple endocrine deficiency, Addison's disease, and candidiasis [syndrome] |
acute angle
| metabolic disease | Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (metabolism, inborn errors) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (12 Dec 1998) |
|---|---|
| metabolic encephalopathy | Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney. (05 Mar 2000) |
| metabolic equivalent | The oxygen cost of energy expenditure measured at supine rest (1 MET = 3.5 ml O2 per kg of body weight per minute); multiples of MET are used to estimate the oxygen cost of activity, e.g., 3 to 5 METs for light work; more than 9 METs for heavy work. (05 Mar 2000) |
| metabolic indican | 1. <chemistry> A glucoside obtained from woad (indigo plant) and other plants, as a yellow or light brown sirup. It has a nauseous bitter taste, a decomposes or drying. By the action of acids, ferments, etc, it breaks down into sugar and indigo. It is the source of natural indigo. 2. <physiology> An indigo-forming substance, found in urine, and other animal fluids, and convertible into red and blue indigo (urrhodin and uroglaucin). Chemically, it is indoxyl sulphate of potash, C8H6NSO4K, and is derived from the indol formed in the alimentary canal. Synonym: uroxanthin. See: Indigo. Source: Websters Dictionary (01 Mar 1998) |
| metabolic mucinosis | Diffuse or pretibial myxoedema, lichen myxoedematosus, gargoylism, secondary mucinosis, degeneration in tumours, localised mucinosis, follicular, papular, plaque-like, focal, and myxoid or synovial cyst. Origin: mucin + G. -osis, condition (05 Mar 2000) |
| metabolic pool | The quantity of a given chemical compound or group of related compounds participating in metabolic reactions; may constitute only a portion of the total bodily content of such compounds. (05 Mar 2000) |
| compensated metabolic alkalosis | The retention of acid, primarily carbon dioxide by the lung and acid ions by the renal tubules, to reduce the effect on the pH of the blood of excess alkali produced by ingestion or metabolism of alkali-producing substances. (05 Mar 2000) |
| skin diseases, metabolic | Diseases of the skin associated with underlying metabolic disorders. (12 Dec 1998) |
| steroid metabolic clearance rate | A measure of the rate of metabolism of a given steroid within the body, usually expressed as liters of body fluid that contain the amount of steroid metabolised per day. (05 Mar 2000) |
| bone diseases, endocrine | Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands. (12 Dec 1998) |
| multiple endocrine adenomatosis | The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance. Synonym: multiple endocrine adenomatosis. (05 Mar 2000) |
| multiple endocrine deficiency syndrome | <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis. Synonym: multiple glandular deficiency syndrome. (05 Mar 2000) |
| multiple endocrine neoplasia | (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour. (type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor. Incidence: approximately 3 in 100,000 people in the general population. Origin: Gr. Plassein = to form (27 Sep 1997) |
| multiple endocrine neoplasia 1 | <radiology> Multiple endrocrine neoplasia syndrome three P's. Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%). Synonym: Wermer syndrome (12 Dec 1998) |
| multiple endocrine neoplasia 2 | <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia Synonym: Sipple syndrome (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|